0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessThis real-world study of relapsing pwMS demonstrates that the benefit of initial HE treatment diminishes with age. However, even in older patients, DMT exposure, regardless of the efficacy level, appears to reduce disability accumulation, and so, on an individual level, initial HE treatment could still be more effective.
Mauro Zaffaroni, Pietro Iaffaldano, Marta Simone, Massimo Filippi, María Trojano, Maria Pia Amato, Emilio Portaccio, M. Betti, Ermelinda De Meo, Luisa Pastò, Lorenzo Razzolini, Francesco Patti, Vincenzo Brescia Morra, Giovanna De Luca, Carlo Pozzilli, Carla Tortorella, Eleonora Cocco, Giuseppe Salemi, Diana Ferraro, Marika Vianello, Giacomo Lus, Alessandra Lugaresi, Matilde Inglese, Gioacchino Tedeschi, Sara Montepietra, Alessia Di Sapio (2025). Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis. , 31(8), DOI: https://doi.org/10.1177/13524585251345317.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2025
Authors
26
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1177/13524585251345317
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
